CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF) hospitalization ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

SAN DIEGO, CA—Among patients with cardiac implantable electronic devices (CIEDs) undergoing tricuspid valve interventions, performing concurrent lead extraction does not appear to carry excess risks, ...

UC San Francisco interventional cardiologists and interventional echocardiographers recently performed two novel minimally invasive cardiac procedures for the first time in the health system.

PARIS — By assessing residual regurgitation after a transcatheter tricuspid valve repair with a four-grade rather than three-grade system, physicians can predict survival more accurately, reported ...

Edwards Lifesciences has secured European approval for its transcatheter tricuspid valve replacement system, which the company described as the first minimally invasive therapy of its kind to receive ...

With the introduction of percutaneous options, the role of surgery in the repair of dysfunctional tricuspid valves is being reevaluated in an effort to reduce the risk for end-stage disease. In the ...

Tricuspid regurgitation is a condition divided into four stages based on several factors. Treatment for the condition varies based on the stage and symptoms and may include watchful waiting or, in ...

Edwards Lifesciences has claimed the FDA’s first approval of a transcatheter replacement implant for a leaky tricuspid heart valve, three months after garnering a green light in Europe. The Evoque, ...

UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using ...

Mitral regurgitation (MR) and tricuspid regurgitation (TR) are two conditions involving backward leakage of blood through a heart valve when a ventricle contracts. People may experience either or both ...

Tricuspid regurgitation develops when the tricuspid valve between the right atrium and right ventricle does not close properly. The tricuspid valve controls the blood flow from the right atrium to the ...